Multidisciplinary Approach for a Successful CLI Management Program

Slides:



Advertisements
Similar presentations
Peripheral Artery Occlusive Disease
Advertisements

Lower Limb Amputations – Level Selection
Infrapopliteal Sirolimus-Eluting Versus Bare Metal Stents for Critical Limb Ischemia: Long-Term Angiographic and Clinical Outcome in >100 Patients Dimitris.
PAD Rehabilitation Toolkit A Guide for Healthcare Professionals Healthy Steps for Peripheral Artery Disease (PAD) Developed by AACVPR and the Vascular.
Evolving Strategies in the Treatment of Peripheral Vascular Disease Ravish Sachar MD, FACC Wake Heart and Vascular.
Single Center Experience with Drug Eluting Stents for Infrapopliteal Occlusive Disease in Patients with Critical Limb Ischemia: Mid-term follow up Robert.
Percutaneous Therapy of Pulmonic and Mitral Valve Disease Atman P. Shah MD FACC FSCAI Director, Coronary Care Unit Assistant Professor of Medicine The.
THE DIABETIC FOOT DR.SEIF I M ELMAHI MD, FRCSI University of Khartoum, Sudan.
For the motion: Endovascular Therapy is a better option for limb salvage in diabetic ulcer treatment Dr. Prasad Jetty Division of Vascular and Endovascular.
Ulcerations Due to Peripheral Vascular Disease
Diabetic Foot: A Surgical Look Mohammed Al-Omran, MD, MSc, FRCSC Assistant Professor & Consultant Vascular Surgery King Saud University.
Francis Dix Consultant vascular and endovascular surgeon
PERIPHERAL VASCULAR DISEASE: A VASCULAR SURGEON’S POINT OF VIEW
Where Art Thou Diabetic Limb Salvage Data?: A Literature Review and Subsequent Challenge to the Diabetic Limb Salvage Community Christine K. Nolan, DPM.
“Outpatient Arteriography and Arterial Intervention in Octogenarians. Is It Safe?” George G. Hartnell Baystate Medical Center Springfield, MA Safe at Any.
{ R. Diaz-Garcia MD, J. Bernardo MD Stem Cell Therapy for Patients with Critical Limb Ischemia: A Meta-analysis with Critical Limb Ischemia: A Meta-analysis.
One stage coronary and peripheral intervention Pawel Buszman, MD, American Heart of Poland, Ustron Silesian Medical School, Katowice.
Atherosclerosis: A Surgical Look
Esiti del trattamento con angioplastica transluminale percutanea (PTA) agli arti inferiori nei pazienti diabetici in trattamento dialitico con ischemia.
MidAtlantic Vascular, LLC Critical Limb Ischemia. P.A.D. Detection, Treatment, and Referral Paul Sasser MD FACS.
MidAtlantic Vascular, LLC
Aims To evaluate the technical and clinical outcome of percutaneous transluminal infra-popliteal angioplasties (PTIA) +/- stenting in a subgroup of patients.
MidAtlantic Vascular, LLC
Post-Surgical Care for the Individual With PAD: A Shared Responsibility to Sustain Life and Limb.
Peripheral Arterial Disease Mohammed Al-Omran, MD, MSc, FRCSC Assistant Professor & Consultant Vascular Surgery King Saud University.
VCU DEATH AND COMPLICATIONS CONFERENCE. Introduction  Complication  Graft infection  Procedure  Femoral-femoral bypass  Primary Diagnosis  Left.
MidAtlantic Vascular, LLC Critical Limb Ischemia. P.A.D. Detection, Treatment, and Referral Paul Sasser MD FACS.
MidAtlantic Vascular, LLC Critical Limb Ischemia. P.A.D. Detection, Treatment, and Referral Paul Sasser MD FACS.
ACC/AHA 2006 guidelines on the management of PAD.
NEW HORIZONS IN DIABETES FOOT CARE IN NIGERIA October 21 st 2015 Afokoghene Rita ISIAVWE FACE Medical Director & Consultant Endocrinologist Rainbow Specialist.
Medical Management of Claudication: Just Walk it Off!!
MidAtlantic Vascular, LLC
Antithrombotic Therapy in Peripheral Artery Disease Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.
Complex Iliac Case Sahil A. Parikh, MD, FACC, FSCAI Assistant Professor of Medicine Director, Center for Research and Innovation Director, Experimental.
Lower Limb Amputations –
The angiosome theory to guide revascularization for CLI
Richard F. Neville, MD Professor, Department of Surgery
Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease   Debbie C. Chen1, Gagan.
Peripheral Interventions in the VA Healthcare System
Approach to CLI – Consider Arterial & Venous Insufficiency
The angiosome concept; open and endovascular treatment of CLI
What is the Optimal Rate of DES Use?
CRT 2012 Venous Disease.
Craig M. Walker, MD Consulting Fees: Spectranetics Corporation
Anticoagulation after peripheral Vascular Intervention
Heavily calcified SFA lesions do not avoid the use of 4 F systems
Complex Ostial Disease of the Aortic Arch Vessels
Michael Siah, M.D. Medstar Georgetown University Hospital
COLUMBUS VASCULAR, VEIN & WOUND CENTER
Director: Center for Critical Limb Care Riverside Methodist Hospital
Craig M. Walker, MD, FACC, FACP Clinical Professor of Medicine
A Global Case Report Form for the Evaluation of Peripheral Interventional Devices Jose Pablo Morales, MD FDA Division of Cardiovascular Devices Center.
Antithrombotic Therapy in Peripheral Artery Disease
LIVE CASE PRESENTATION MOUNT SINAI CARDIAC CATH LAB
Niv Ad, MD Chief, Cardiac Surgery Professor of Surgery, VCU
Eric J Dippel, MD FACC Davenport, Iowa, USA February 19, 2017
CURRENT TREND OF DIABETIC FOOT SURGERY IN GENERAL HOSPITAL OF KSA: ARE WE DOING ENOUGH TO AVOID AMPUTATIONS? Dr. Anthony Morgan, Dr. Adel Mohammad bin.
Instent Restenosis and Occlusion: Time for Surgical Revision?
Peripheral Arterial Disease
Post-Surgical Care for the Individual With PAD
VASCULAR SURGERY STATIONS
Benefit of immediate revascularization in women with critical limb ischemia in an intention-to-treat analysis  Jana Ortmann, MD, Eveline Nüesch, PhD,
Biomedical Engineering for Global Health
Surgical or endovascular revascularization in patients with critical limb ischemia: Influence of diabetes mellitus on clinical outcome  Florian Dick,
Division of Endovascular Interventions
Limb Preservation Center:The New Frontier
From Theory to Practice: Creating a limb Preservation Center
Gabor Libertiny, FRCS, Linda Hands, MS, FRCS 
DFU—The Facts You Need to Know
Konstantinos Katsanos Joseph Mills Sigrid Nikol Jim Reekers
Presentation transcript:

Multidisciplinary Approach for a Successful CLI Management Program Craig M. Walker, MD, FACC, FACP Clinical Professor of Medicine Tulane University School of Medicine New Orleans, LA LSU School of Medicine Founder, President, and Medical Director Cardiovascular Institute of the South Houma, LA Clinical Editor Vascular Disease Management Global Vascular Digest

Disclosures Speaker’s Bureau: Abbott Bard Boehringer-ingelheim Bristol-Myers-Squibb/Sanofi Cardiva Cook Medical Cordis DSI/Lilly Gore ACHL/Merck Spectranetics PVD Training: Boston Scientific TriReme Medical Stockholder: CardioProlific Cardiva Spectranetics Vasamed Consultant/Medical/Scientific Boards: Abbott Boston Scientific Cook Medical CR Bard Lake Regional Medical Medtronic

There is an epidemic of PVD Mary Yost of the Sage Group estimates up to 20 million Americans have PVD. In 2006 between 1 million and 2.5 million people in the U.S. had CLI. (Estimated this will grow to 2.8 million by 2020). PAD is a marker for death with 1 year mortality or major CV event rates of 20%. The Majority of patients with PAD or either asymptomatic or ascribe their symptoms to etiologies other than PAD. THE OVERWHELMING MAJORITY OF PATIENTS WITH PAD ARE UNDIAGNOSED.

Patient Survival by Ankle-Brachial Index in Cardiovascular Health Study Newman et al ATVB 1999;19:538-545

CLI is not created Equal Rest Pain (Rutherford 4) Ischemic Ulceration (Rutherford 5) Gangrene (Rutherford 6) Severe Infection worsens prognosis Major tissue loss worsens prognosis Comorbid conditions worsen prognosis

It is not conservative treatment to amputate! Amputations Less than 20% get an angiogram Only 50% get an ABI Most of these patients do have limb salvage options It is not conservative treatment to amputate! David E Allie, MD, Craig M. Walker, MD: Critical Limb Ischemia: A Global Epidemic. A Critical Analysis of Current Treatment Unmasks the Clinical and Economic Costs of CLI. Eurointervention Journal, 2005, 1, 1, 75-84.

Amputation (Impact!!) 160,000 per year in the US 20%-25% (1/4) all diabetics-lifetime 30 Day perioperative mortality BKA - 5-8% AKA - 8-12% 18 - 24 month overall mortality - 40-50% Amputations are NOT benign! David E Allie, MD, Craig M. Walker, MD: Critical Limb Ischemia: A Global Epidemic. A Critical Analysis of Current Treatment Unmasks the Clinical and Economic Costs of CLI. Eurointervention Journal, 2005, 1, 1, 75-84.

“For some reason, it is considered conservative treatment to chop someone’s leg off and aggressive treatment to even do an angiogram”

Treating PVD Primary Treatment for severe PVD in the 1800’s

Treating PVD In some places Primary Treatment for severe PVD in 2017

Keys to avoiding amputation Earlier diagnosis Earlier appropriate medical therapy Earlier referral for revascularization Revascularization (straight line flow to foot) Infection control and nutritional support Wound care/Minor amputation in some cases Unloading and cushioning Hyperbaric therapy

We need Limb Salvage Teams No patient should have a major amputation without TEAM evaluation Components of TEAM Nurse Coordinator Interventionists Open Surgical Revascularization Infectious Disease Podiatry Diabetologists Wound Healing Experts Dialysis Smoking Cessation

Limb Salvage Teams (cont.) Perform continued medical education Routine Screening (the earlier the disease is diagnosed, the better the long-term prognosis) COMMUNICATION

Who is a candidate for limb salvage “There is no patient facing major amputation on whom I would not consider intervention except: Cases of true acute limb ischemia with totalloss of neurological function where reperfusion could result in severe complications including death with no benefit. or extensive deep infection that can’t be treated.”

Goals of the Interventionalist in Limb Salvage Establish straight line flow to the foot At least long enough to heal the ulcer Avoid further trauma Never take away a surgical option Never make things worse Limit iodinated contrast (CO2 is an option) Avoid stenting at surgical areas Avoid occlusive sheaths Avoid distal wire complications ( Spasm, dissection, perforation, etc.)

Case: 27 Year old Female Nurse, Single Mom Pre-Intervention

Actual Operative Report Date of Procedure: 08/24/09

Left Side

1 Month Post Intervention

Conclusion Amputations are not benign Amputations carry high morbidity/mortality rates and cost more than limb salvage. Earlier diagnosis and treatment improve outcomes Newer revascularization and wound healing techniques are yielding improved results No one should ever be subjected to amputation without access to CLI team